WithdrawnNot Applicable

BOND Study: the Benefit Of Night Splinting in Dupuytrens'

Stopped: Intervention (Xiapex) was removed from the market

United Kingdom0Started 2017-06-01

Plain-language summary

The BOND study is a prospective, randomised single blinded controlled trial to assess the effect of night splinting in patients who have had collagenase injection and manipulation therapy for Dupuytren's Contracture.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Single digit contractures greater than 30 degrees
✓. No prior surgery for their contractures.
✓. Successful collagenase and manipulation therapy (contracture reduced to within 10 degrees of full extension).

Exclusion criteria

✕. Multiple digit contractures
✕. Prior surgery for their contractures.
✕. Failure of collagenase and manipulation therapy (contracture not reduced to within 10 degrees of full extension).
✕. Inability to consent to treatment.

What they're measuring

Range of motion

Timeframe: At 0 weeks, 12 weeks and 52 weeks

Trial details

NCT IDNCT03031080

SponsorLiverpool University Hospitals NHS Foundation Trust

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2018-12-31

View on ClinicalTrials.gov More Dupuytren Contracture trials